Istituto di Ricerche Farmacologiche "Mario Negri"

Fingerprint Dive into the research topics where Istituto di Ricerche Farmacologiche "Mario Negri" is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Italy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Kidney Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Odds Ratio Medicine & Life Sciences
Case-Control Studies Medicine & Life Sciences
Confidence Intervals Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Diego Albani

Diego Albani

Person: Academic

19992019
No photo of Renzo Bagnati

Renzo Bagnati

Person: Academic

19872018
No photo of Claudia Balducci

Claudia Balducci

Person: Academic

19962019

Projects 2019 2019

MARIO NEGRI - STUDI FARMACOLOGICI E CLINICI NELLE MALATTIE NEUROLOGICHE

Ricerca, U.

1/1/19 → 12/31/19

Project: Other project

MARIO NEGRI - STUDI FARMACOLOGICI E CLINICI SU PATOLOGIE ASSOCIATE AD ESPOSIZIONE AMBIENTALE CON PARTICOLARE RIFERIMENTO ALLE MALATTIE RENALI CRONICHE

Ricerca, U.

1/1/19 → 12/31/19

Project: Other project

MARIO NEGRI - STUDI FARMACOLOGICI E CLINICI NELLE MALATTIE RARE

Ricerca, U.

1/1/19 → 12/31/19

Project: Other project

Research Output 1952 2020

A validation study of the clinical diagnosis of Dup15q syndrome: Which symptoms matter most?

Beghi, E., Giussani, G., Bianchi, E., Randazzo, G., Sarcona, V., Elia, M., Striano, P., Verrotti, A., Ferretti, A., Rebessi, E., Specchio, N. & Bonanni, P., Jan 2020, In : Seizure. 74, p. 26-30 5 p.

Research output: Contribution to journal › Article

2 Citations (Scopus)

Mobility Disorders in Stroke, Parkinson Disease, and Multiple Sclerosis: A Multicenter Cross-Sectional Study

NEUROFALL Group, Jan 1 2020, In : American journal of physical medicine & rehabilitation. 99, 1, p. 41-47 7 p.

Research output: Contribution to journal › Article

Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: 12-month TWEYEs study

Bandello, F., Staurenghi, G., Ricci, F., Midena, E., Viola, F., Lupieri Sinibaldi, T., Colombo, L., Peruzzi, E. & Bassanini, S., 2020, In : British Journal of Ophthalmology. 104, 1, p. 64-73

Research output: Contribution to journal › Article

Open Access
Macular Degeneration
Safety
Visual Acuity
Drug-Related Side Effects and Adverse Reactions
Incidence